Open House Original Discount Agreements 2023-29 - Dolutegravir/Lamivudine (Combination Of Active Ingredients)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 71598848

  Document Type - Tender Notices

Description - The health insurance companies involved pursue the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 SGB V for the active ingredient combination dolutegravir/lamivudine. The contract is concluded as part of the health insurance companies' open house originals procedure: Individual negotiations about contract contents are not conducted; uniform conditions apply. The health insurance companies do not guarantee individual contractual partners exclusivity. The contract term is a maximum of 24 months starting on November 1st, 2023. The contract ends on October 31, 2025 at the latest, regardless of the date the contract wa

Gt Ref Id - 71598848

Deadline - Oct 31, 2025